Vaccine. 2009 Sep 18;27(41):5685-91. Epub 2009 Jul 17.

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine.

Russell FM, Balloch A, Tang ML, Carapetis JR, Licciardi P, Nelson J, Jenney AW, Tikoduadua L, Waqatakirewa L, Pryor J, Byrnes GB, Cheung YB, Mulholland EK.

Source

Centre for International Child Health, Murdoch Childrens Research Institute, Department of Paediatrics, University of Melbourne, Victoria, Australia. fionarussell@connect.com.fj

Abstract

The aim was to identify an appropriate infant pneumococcal vaccination strategy for resource poor countries. Fijian infants received zero, one, two, or three doses of 7-valent pneumococcal conjugate vaccine (PCV) in early infancy. Following three PCV doses, geometric mean concentration (GMC) to all seven serotypes were > or = 1.0 microg/mL, and >85% of children achieved antibody levels > or = 0.35 microg/mL at 18 weeks. Following two doses, GMC were lower for 6B, 14, and 23F, but higher for 19F compared with three doses. Following a single dose, significant responses were seen for all serotypes post-primary series compared with the unvaccinated. By 12 months, differences between two and three doses persisted for serotype 14 only. Although GMC following three doses are higher than after two doses, the differences were small. A single dose may offer some protection for most serotypes.

PMID:: 19616498; [PubMed - indexed for MEDLINE]
PMCID:: PMC2734870

Free PMC Article

Images from this publication.See all images (1) Free text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Pneumococcal Infections - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa. [Pediatr Infect Dis J. 2002]
Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa.
Huebner RE, Mbelle N, Forrest B, Madore DV, Klugman KP. Pediatr Infect Dis J. 2002 Nov; 21(11):1004-7.
Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months. [Vaccine. 2011]
Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.
Russell FM, Balloch A, Licciardi PV, Carapetis JR, Tikoduadua L, Waqatakirewa L, Cheung YB, Mulholland EK, Tang ML. Vaccine. 2011 Jun 15; 29(27):4499-506. Epub 2011 May 1.
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. [Pediatrics. 2010]
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.
Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA, PCV13 Infant Study Group. Pediatrics. 2010 May; 125(5):866-75.
Review Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: a systematic review and meta-analysis. [Vaccine. 2011]
Review Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: a systematic review and meta-analysis.
Rückinger S, Dagan R, Albers L, Schönberger K, von Kries R. Vaccine. 2011 Dec 6; 29(52):9600-6. Epub 2011 Sep 18.
Review Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine. [Expert Rev Vaccines. 2009]
Review Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine.
Dinleyici EC, Yargic ZA. Expert Rev Vaccines. 2009 Aug; 8(8):977-86.

See reviews... See all...

Cited by 3 PubMed Central articles

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age. [Vaccine. 2011]
Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.
Russell FM, Carapetis JR, Burton RL, Lin J, Licciardi PV, Balloch A, Tikoduadua L, Waqatakirewa L, Cheung YB, Tang ML, et al. Vaccine. 2011 Jan 10; 29(3):535-44. Epub 2010 Oct 31.
Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster. [Clin Vaccine Immunol. 2010]
Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.
Russell FM, Carapetis JR, Satzke C, Tikoduadua L, Waqatakirewa L, Chandra R, Seduadua A, Oftadeh S, Cheung YB, Gilbert GL, et al. Clin Vaccine Immunol. 2010 Dec; 17(12):1970-6. Epub 2010 Oct 13.
Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy. [Vaccine. 2010]
Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy.
Russell FM, Licciardi PV, Balloch A, Biaukula V, Tikoduadua L, Carapetis JR, Nelson J, Jenney AW, Waqatakirewa L, Colquhoun S, et al. Vaccine. 2010 Apr 19; 28(18):3086-94. Epub 2010 Mar 1.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal c...
Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine.
Vaccine. 2009 Sep 18 ;27(41):5685-91. Epub 2009 Jul 17 .

PubMed
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced...
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.
Vaccine. 2009 Sep 4 ;27(40):5488-95. Epub 2009 Jul 17 .

PubMed
Survey of current job functions of renal dietitians.
Survey of current job functions of renal dietitians.
J Ren Nutr. 2009 Nov ;19(6):450-61. Epub 2009 Jul 17 .

PubMed
Dynamic leaching test of personal computer components.
Dynamic leaching test of personal computer components.
J Hazard Mater. 2009 Nov 15 ;171(1-3):1058-65. Epub 2009 Jun 27 .

PubMed
Cellular and molecular pathways linking inflammation and cancer.
Cellular and molecular pathways linking inflammation and cancer.
Immunobiology. 2009 ;214(9-10):761-77. Epub 2009 Jul 17 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: